Abbott Laboratories has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s ...
Abbott is the name behind many well-known products.
"Boring" may be just what the doctor ordered in this volatile market.
Abbott Laboratories is delivering double-digit percentage earnings growth along with a dependable dividend.
If you are wondering whether Abbott Laboratories is attractively priced or just fairly valued at current levels, you are not alone. This article will help you put the current share price in context.
The stock's fall snapped a five-day winning streak.
Abbott Laboratories’ stock took a direct hit, wiping out nearly 10% of its market value following its Q4 earnings. Response? The CEO bought $2 million shares. Robert B. Ford, CEO of Abbott ...
Abbott Laboratories (NYSE:ABT) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February ...
Abbott Laboratories closed 20.22% short of its 52-week high of $141.23, which the company reached on March 4th.
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Disclosed on November 25, Eric Shroff, Senior Vice President at Abbott Laboratories (NYSE:ABT), executed a substantial insider sell as per the latest SEC filing. What Happened: Shroff's decision to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results